E-LIB Suche - Ergebnisse für: Offin, M.

1

169P Phase I dose escalation trial combining olaparib and t..:

Rimner, A. ; Lok, B. ; Gelblum, D.Y....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S133 , 2023

Link: https://doi.org/10.1016/..

2

P2.09-14 Clinical Characteristics and Outcomes of Patients ..:

Sui, J. ; Yang, S.R. ; Bowman, A.S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S337 , 2023

Link: https://doi.org/10.1016/..

3

Abstract No. 13 Safety and Efficacy of Percutaneous Cryoabl..:

Alexander, E. ; Petre, N. ; Offin, M....
Journal of Vascular and Interventional Radiology. 34 (2023) 3 - p. S8 , 2023

Link: https://doi.org/10.1016/..

4

EP12.02-08 Frequency and Outcomes of Leptomeningeal Metasta..:

Chen, M. ; Sui, J. ; Wilcox, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S677 , 2023

Link: https://doi.org/10.1016/..

5

P2.10-06 Brain Metastases in Patients with Fusion-Positive ..:

Sui, J.S. ; Chen, M.F. ; Wilcox, J....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S354 , 2023

Link: https://doi.org/10.1016/..

6

Tumor Mutational Burden Predicts Progression-Free Survival ..:

Shaverdian, N. ; Shepherd, A.F. ; Offin, M....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e390-e391 , 2022

Link: https://doi.org/10.1016/..

7

EP05.01-025 Planned Interim Analysis of a Phase II Trial of..:

Rimner, A. ; Fitzgerald, K. ; Iqbal, A.N....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S278 , 2022

Link: https://doi.org/10.1016/..

8

Pre-Treatment Immune-Related Markers Predict Disease Outcom..:

Thor, M. ; Shepherd, A.F. ; Apte, A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. S11 , 2021

Link: https://doi.org/10.1016/..

9

The Correlation Between Changes in Cardiac Biomarkers and C..:

Shepherd, A.F. ; Yu, A. ; Margaret, C.A....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e450-e451 , 2021

Link: https://doi.org/10.1016/..

10

Characterization and management of ERK inhibitor associated..:

Wu, J. ; Liu, D. ; Offin, M....
Investigational New Drugs. 39 (2021) 3 - p. 785-795 , 2021

Link: https://doi.org/10.1007/..

11

A Pre-Treatment PET And CT-Derived Model for Progression-Fr..:

Thor, M. ; Fitzgerald, K.J. ; Apte, A....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e87 , 2020

Link: https://doi.org/10.1016/..

12

Exploring Associations between Immune Parameters and Radiat..:

Thor, M. ; Shaverdian, N. ; Shepherd, A.F....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e114 , 2020

Link: https://doi.org/10.1016/..

13

Durvalumab with Concurrent Definitive Radiation Therapy (DA..:

Rimner, A. ; Offin, M. ; Shaverdian, N....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e929 , 2020

Link: https://doi.org/10.1016/..

14

One-Year Disease Outcomes in Stage III Non-Small Cell Lung ..:

Shaverdian, N. ; Shepherd, A.F. ; Offin, M....
International Journal of Radiation Oncology*Biology*Physics. 108 (2020) 3 - p. e113 , 2020

Link: https://doi.org/10.1016/..

15

Real-World Evaluation of Consolidative Durvalumab in Locall..:

Shaverdian, N. ; Zhang, Z. ; Lobaugh, S....
International Journal of Radiation Oncology*Biology*Physics. 105 (2019) 1 - p. E531 , 2019

Link: https://doi.org/10.1016/..